Racial Disparities in COVID-19 Outcomes Among Black and White Patients With CancerJulie Fu, Philip E. Lammers, Sonya Reid et al.|JAMA Network Open|2022Cited by 73
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter StudyJingran Ji, Jonathan W. Riess, Jacqueline V. Aredo et al.|JTO Clinical and Research Reports|2023Cited by 39
Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study.Jingran Ji, Jonathan W. Riess, Jacqueline V. Aredo et al.|Journal of Clinical Oncology|2020Cited by 18
Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic CenterLeyre Zubiri, Kerry L. Reynolds, David P. Ryan et al.|The Oncologist|2021Cited by 18
Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19Isaac A. Klein, Ann H. Partridge, Shoshana M. Rosenberg et al.|The Oncologist|2021Cited by 8